Our Distinguished Speakers


Prof. Dr. Christoph Herwig

Head of Institute of Biotechnology and Chemical Engineering,
Vienna University of Technology Institute of Chemical Engineering

Christoph Herwig, bioprocess engineer from RWTH Aachen, worked in industry in the design and commissioning of large chemical facilities prior to enter his interdisciplinary PhD studies at EPFL, Switzerland in bioprocess identification. Subsequently he positioned himself at the interface between bioprocess development and facility design in biopharmaceutical industry. Since 2008, he has been appointed to a professor for biochemical engineering at the Vienna University of Technology. The research area focuses on the development of data science methods for integrated and efficient bioprocess development along PAT and QbD principles for biopharmaceuticals. In 2013 he founded the company Exputec addressing data science solutions for the biopharma life cycle.


Dr. Frank Wartenberg

President Central Europe IQVIA,
IQVIA Commercial GmbH & Co. OHG

Dr. Frank Wartenberg has been President Central Europe since 2011 and IQVIA's representative in Germany since the merger of Quintiles and IMS HEALTH 2016. As part of his role he owns the full P&L responsibility for Germany and Austria. Prior to 2010, as VP and Practice Leader Commercial Effectiveness, he was responsible for IMS HEALTH's consulting business for sales and marketing in EMEA.

Frank regularly shares his opinions with board members and senior management of the pharmaceutical industry in invited presentations, workshops and private discussions. He is a regular speaker at industry conferences on industry trends and regularly publishes in international and national journals.

Since April 2018, he has been appointed as chairman of the Federal Commission for Digital Health of the Economic Council (“Wirtschaftsrat”) in Germany. Also, with effect from June 2018, he was appointed to the EMEA Regional Advisory Committee of DIA, a global research network.

Prior to joining IMS Health, he has built a consulting business in the pharmaceutical industry as General Manager and co-founder of scicon, a midsized consulting company focusing on the health care industry which became part of IMS HEALTH in 2004.

Frank's academic background includes a diploma in management science and operations research and a doctorate in economics of the University of Karlsruhe, Germany. He also studied history and philosophy.


Woody Hydrick

WH-Consulting Owner,
WH-Consulting USA (Former Cushman & Wakefield)

With more than 20 years of experience, Woody provides location advisory consulting services for capital investment projects including new developments, relocations, expansions or consolidations. In his career, he has executed site searches for clients throughout North America, South America, Europe, and Asia for manufacturing, distribution and back office operations representing billions of dollars in capital investments and thousands of jobs. He has extensive experience in life sciences and has executed siting studies across the world for some of the industry’s largest companies.

Prior to starting his own firm in 2018, Woody spent the last five years as an owner and Managing Director of Global Location Strategies (GLS), a site selection consultancy located in Greenville, South Carolina. Prior to GLS, Woody was a Managing Director in the Global Business Consulting practice of Cushman & Wakefield, one of the world’s largest commercial real estate companies, where he managed the World Market Access practice. Prior to C&W, Woody served as a Project Manager for Fluor Corporation’s site selection practice.


Luca Mussati

Exyte Management GmbH,
Vice President Life Sciences and Chemicals, Exyte GBU-LSC, Stuttgart, Germany

Luca Mussati holds a degree in Chemical Engineering from the Polytechnic of Milan. In his 30 years of professional career with major engineering companies, Luca managed the design, construction, commissioning and qualification of large state-of-the-art Life Sciences facilities in Europe and abroad. Currently based in Germany, he is actively developing innovative delivery approaches for the realization of drug production units.


Dr. Oliver Bartelsen

Miltenyi Biotech GmbH,
Global Head of Business Development and Industrial Services Miltenyi Biotec GmbH

As the Head of Business Development at Miltenyi Biotec, Oliver is responsible for the Company’s strategic collaborations with Biotech and Pharma in Cell and Gene Therapy (CGT). Joining Miltenyi Biotec in 2009, he has been instrumental to build the Company’s industry business becoming a global solution provider in the CGT field addressing challenges in development, manufacturing and testing of CGT products. Based on Miltenyi Biotec’s foundations of its tool and reagent catalogue business, Oliver and his team are doing deals with the CGT industry from strategic supply to R&D collaborations in technology platform and CGT product development and contract manufacturing.

Before joining Miltenyi Biotec, Oliver worked in the vaccine industry in positions with increasing responsibilities in R&D, project management, industrialization and business development at Rhein Biotech, GreenCross Vaccine, Berna Biotech, Crucell and Dynavax. Oliver holds a doctoral degree in Biochemistry from the University of Bonn, Germany.